EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Updates in the Management of Richter Transformation

Noa Rippel iD, Richard Sheppard iD, Adam S Kittai

Cancers · 31.12.2024 · 17 (1) · 95

DOI: 10.3390/cancers17010095 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 31.12.2024. Verfasst von Noa Rippel und 2 weiteren Autor:innen. Beteiligte Einrichtung: Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 88 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Richter transformation (RT) is a rare albeit devastating complication of chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL). RT is defined as an aggressive lymphoma, typically diffuse large B-cell lymphoma, in the setting of CLL. A clonal relationship to the preceding CLL clone is detected in the majority of RT cases and confers more aggressive clinicopathologic kinetics, resistance to standard chemoimmunotherapy regimens, and inferior survival. Taken together, these considerations precipitate a significant unmet need for novel therapeutic strategies that improve the outcomes of patients with RT. Through this review, we will explore current data on emerging regimens targeting BTK, BCL-2, CD79, CD20, PI3K, and PD-1—both as single agents and as combination therapies with or without concurrent chemoimmunotherapy. Furthermore, we will review the role of bispecific T-cell engagers, anti-CD19 chimeric antigen receptor T-cell therapies, and hematopoietic stem cell transplantation in RT. To guide therapeutic decision-making, we will outline an algorithmic approach to the management of RT, with particular emphasis on prioritization of clinical trial enrollment and utilization of an ever-evolving array of novel therapies.

Schlagwörter

Stichwörter der Autor:innen

CLLRichter transformationtargeted therapies

Autor:innen und Institutionen

  • Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.

ORCID-Profile: Noa Rippel, Richard Sheppard

Zitieren

APA

Rippel, N., Sheppard, R., & Kittai, A. S. (2024). Updates in the Management of Richter Transformation. Cancers, 17(1), 95. https://doi.org/10.3390/cancers17010095

Vancouver

Rippel N, Sheppard R, Kittai AS. Updates in the Management of Richter Transformation. Cancers. 2024;17(1):95. doi:10.3390/cancers17010095

BibTeX
@article{Rippel2024,
  author = {Rippel, Noa and Sheppard, Richard and Kittai, Adam S},
  title = {Updates in the Management of Richter Transformation},
  journal = {Cancers},
  year = {2024},
  volume = {17},
  number = {1},
  pages = {95},
  doi = {10.3390/cancers17010095}
}
Kostenlos starten →